Ali Denktas M.D., FACC, FSCAI
Dr. Denktas joined The University of Texas Medical School at Houston in March 2005 as an Assistant Professor of Medicine. From 1997-2000 Dr. Denktas was a Clinical Fellow in The Division of Cardiology. He completed his internal medicine residency training at Mayo Clinic in Rochester, Minnesota and Istanbul University Cerrahpasa. Dr. Denktas received the Dean’s Teaching Excellence Award in 2006. In 1999 he was awarded the Leadership in Cardiology Research and was the top student at the Istanbul University Cerrahpasa in 1992. He is currently a member of the Society for Cardiovascular Angiography and Interventions, the American College of Cardiology and a faculty interviewer for Medical School Admissions. Dr. Denktas is also actively involved in the teaching rounds in CCU to Cardiology residents and fellows. Dr. Denktas’ clinical interests include interventional cardiology, peripheral vascular intervention, valvular heart disease, aortic and mitral valvuloplasty, radiation brachytherapy for in-stent restenosis, percutaneous closure of patent foramen ovale and atrial septal defects in adults with cryptogenic stroke and significant left-to-right or right-to-left shunt, carotid stenting, and interventional treatment of atherosclerotic cerebrovascular disease. Dr. Denktas’ current research projects include a Phase I randomized, double-blind, placebo-controlled, dose-escalation study to determine the safety of intravenous ex-vivo cultured human mesenchymal stem cells following acute myocardial infarction. Also, Phase II: A long-term follow-up to evaluate the safety of adult human mesenchymal stem cells in subjects following acute myocardial infarction. Dr. Denktas is the author of 22 original articles, 27 abstracts, 5 invited articles, 7 book chapters, and 11 other professional communications.